ALGLUCOSIDASE ALFA | B125291 | GENZYME
Regulatory Exclusivities
| Type | Expiry | Status | Source |
|---|---|---|---|
| 12-Year BPCIA | May. 24, 2022 | Expired | Computed |
Purple Book Patents
No listed patents in Purple Book.
Estimated Patent LOE
Based on latest discovered patent 12414985(composition) · relevance 88/100
Estimate based on AI-discovered patents. No patents are officially listed in the Purple Book for this product.
Top 50 of 99 AI-discovered patents by relevance.
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from Stira Pharmaceuticals LLC FDA-2026-P-9043 Stira Pharmaceuticals LLC filed a citizen petition requesting that the FDA take specific regulatory action regarding drug development and approval processes. The petition seeks FDA guidance or policy clarification on matters related to pharmaceutical development, though the specific drug product nam | Other | 2026-08-11 | Open | Stira Pharmaceuticals LLC |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.